What is ATAC and how does it support the advanced therapies industry? Cell and Gene Therapy Catapult 2021-02-23 | The Advanced Therapies Apprenticeship Community (ATAC) has been established to develop talent, from manufacturing operatives to technical and regulatory experts and researchers, to support the growth and development of the advanced therapy industry.Visit advancedtherapiesapprenticeships.co.uk for more information.
Cell and Gene Therapy Catapult London Office and Laboratories Cell and Gene Therapy Catapult 2024-10-21 | CGT Catapult London, located at Guy’s Hospital, is a 1,200 metre square facility which includes technology and process innovation laboratories for cell and gene therapy process development. We provide the collaborative environment, specialised equipment and people to overcome product development barriers, supporting you to progress your product to the next stage of the ATMP development pathway.
Enhancing the UK environment for advanced therapy clinical trials - ATTC network event 2024 Cell and Gene Therapy Catapult 2024-10-15 | To celebrate the new £17.9m funding that the Advanced Therapy Treatment Centres (ATTC) network has received to continue its work, provided by NIHR and Innovate UK, the network hosted an event focusing on enhancing the UK environment for advanced therapy clinical trials.This event, which brought together members from across the healthcare sector, including clinicians, regulators and patient advocates, also recognised the exciting addition of a new ATTC, the London Advanced Therapies ATTC, which will join the Innovate Manchester Advanced Therapies Treatment Centre Hub, Midlands-Wales ATTC and the Northern Alliance ATTC.Learn more: theattcnetwork.co.uk
Why choose an ATAC apprenticeship? Cell and Gene Therapy Catapult 2024-04-04 | Explore the benefits of an Advanced Therapies Apprenticeship Community (ATAC) apprenticeship through first-hand experiences shared by two of our current apprentices.For more information, please visit - advancedtherapiesapprenticeships.co.uk
Introducing the CGT Catapult Braintree Manufacturing Innovation Centre Cell and Gene Therapy Catapult 2024-01-19 | Our Braintree Manufacturing Innovation Centre (MIC) is a 4,627m2 facility uniquely equipped to help accelerate the development of GMP manufacturing operations for advanced therapies at a clinical and commercial scale. Having secured MHRA regulatory licensure in early 2024, our facility has the infrastructure to support your viral vector and cell and gene therapy manufacturing needs.Learn more: ct.catapult.org.uk/facilities/braintree
Cell and Gene Therapy Catapult ATMP GMP Manufacturing Report 2023 Cell and Gene Therapy Catapult 2023-12-15 | The Cell and Gene Therapy Catapult (CGT Catapult) conduct an annual survey on ATMP GMP Manufacturing capacity and capability in the UK. In this video, Dr Stephen Ward, Chief Manufacturing Officer at CGT Catapult, highlights the findings presented in our 2023 ATMP GMP Manufacturing Report.
Employee Spotlight: Shereece Szelwicki, Senior Tech Transfer Specialist Cell and Gene Therapy Catapult 2023-08-29 | Hear from Shereece Szelwicki, a Senior Tech Transfer Specialist at CGT Catapult. In her testimonial, she talks about how CGT Catapult invests in staff training and how this played a key role in her seamless transition from a prior sector.
Employee Spotlight: Ryan McCoy, Senior Regulatory Affairs Manager Cell and Gene Therapy Catapult 2023-08-29 | Hear from Ryan McCoy, a Senior Regulatory Affairs Manager at CGT Catapult. In this video, he talks about his career milestones and the opportunities he received along the way as well as the meaningful projects we worked on.
Employee Spotlight: Sophie Gurkin, GMP Trainer Cell and Gene Therapy Catapult 2023-08-25 | Hear from Sophie Gurkin, a former GMP Trainer and now a Collaborators Project Manager at CGT Catapult. In her testimonial, Sophie shares her experiences while working as a GMP Trainer and how CGT Catapult has provided her with various opportunities to develop skills and advance her career.
Employee Spotlight: Serkan Ahmet, IT Service Delivery Team Leader Cell and Gene Therapy Catapult 2023-08-25 | Hear from Serkan Ahmet, an IT Service Delivery Team Leader at CGT Catapult. In this video, he talks about the key projects he worked on and how the organisation supported his growth and career trajectory.
Employee Spotlight: Sam Dimond, Marketing and Events Executive Cell and Gene Therapy Catapult 2023-08-25 | Hear from Sam Dimond, a Marketing and Events Executive at CGT Catapult. In this testimonial, he talks about his journey with us, highlighting the rewarding experiences and opportunities he has had while working in this role.
Introducing the Cell and Gene Therapy Catapult Edinburgh office and laboratories Cell and Gene Therapy Catapult 2023-06-06 | CGT Catapult Edinburgh is a 350m2 high-specification laboratory equipped with manufacturing development and analytical technologies for cell therapies. Bridging the gap between our Technology and Process Innovation laboratories in London and our Stevenage Manufacturing Innovation Centre, our Edinburgh facility is uniquely positioned to support the maturation of your novel cell therapy manufacturing process.We provide the resources and knowledge needed for you to progress your cell therapy through to clinical trials. Our Edinburgh team comprises of technical, GMP and clinical adoption experts from across the cell therapy life cycle, providing the workforce to assess and de-risk your process and advise on the regulatory requirements associated with bringing your therapy to market.Based at the Edinburgh BioQuarter, in the University of Edinburgh’s Institute for Regeneration and Repair, our facility is strategically aligned with academic strength in stem cell research in the North of the UK and the strong CDMO and Pharmaservices offering in Scotland. Here, we continue to support research investment, networking, spin-out and building on the local cell and gene therapy cluster. We use our extensive network to facilitate connections between academic groups, early-stage therapy developers, NHS, CROs and CDMOs to further support an accelerated route to the clinic.Making the cell and gene therapy industry accessible to allAlong with the high-specification manufacturing development labs, the facility also includes a 60m2 ‘Universal Design’ lab for scientists with physical disabilities, the UK’s first accessible laboratory specifically designed for cell and gene therapies. As a world-wide exemplar of an advanced therapies laboratory built to the principles of universal design, the facility aims to widen participation in the industry and increase opportunities for scientists to take up a career in cell and gene therapies irrespective of physical ability.
Introducing the Cell and Gene Therapy Catapult’s Process Analytical Technologies Laboratory Cell and Gene Therapy Catapult 2023-04-19 | A space for cell and gene therapy developers to ensure the quality of their advanced therapy products is maintained as they scale-up production.Process Analytical Technologies help developers gain greater understanding and real-time control of manufacturing processes.Based in Stevenage UK, the Process Analytical Technologies Laboratory provides additional capability to the already extensive existing offering of the Cell and Gene Therapy Catapult.Our collaborators can use innovative in-line and at-line monitoring equipment to identify and assess critical process parameters in real-time, while state-of-the-art automation and digitalisation facilitates rapid control of these critical process parameters during production.Contact us here ct.catapult.org.uk/contact to learn more about our extensive experience in the application of Process Analytical Technologies.
Introducing the Cell and Gene Therapy Catapult Cell and Gene Therapy Catapult 2022-03-28 | CGT Catapult is an independent innovation and technology organisation committed to the advancement of cell and gene therapies, with a vision for a thriving industry delivering life-changing advanced therapies to the world.We are a team of experts covering all aspects of advanced therapies. Applying our unique capabilities and assets, we collaborate with academia, industry, and healthcare providers to develop new technology and drive innovation.Learn more about how we can support you: ct.catapult.org.uk
ATSTN Walkthrough Video Cell and Gene Therapy Catapult 2021-08-16 | The Advanced Therapies Skills Training Network (ATSTN) connects training and educational resources from across the advanced therapy and vaccine manufacturing industry, offering access to training facilities and an online training platform which can address the UK’s demand for skills.
Highlights from the first year at CGT Catapult Braintree Cell and Gene Therapy Catapult 2021-07-23 | Cell and Gene Therapy Catapult celebrates one-year anniversary since receiving funding from the Department of Business, Energy and Industrial Strategy to setup its world-class Manufacturing Innovation Centre (MIC) in Braintree, Essex 🎂Learn more about CGT Catapult Braintree: ct.catapult.org.uk/facilities/braintree
Meet the ATAC Apprentices Cell and Gene Therapy Catapult 2021-03-09 | Want to know what apprenticeships in advanced therapies are really like? We asked our community for their experiences and opinions. So if you are wondering if an apprenticeship is right for you, why not hear what they have to say?Visit advancedtherapiesapprenticeships.co.uk for more information
Welcome to ATAC Cell and Gene Therapy Catapult 2021-02-23 | The Advanced Therapy Apprenticeship Community (ATAC) is the first apprenticeship programme designed specifically to train and upskill individuals in developing, manufacturing and delivering advanced therapies at scale.ATAC offers a unique experience by ensuring that apprenticeships are tailored to suit specialist industry needs, and also provides apprentices and employers additional support and industry-led activities to complement programmesVisit advancedtherapiesapprenticeships.co.uk for more information
Advanced Therapies Apprenticeship Programmes in England Cell and Gene Therapy Catapult 2021-02-23 | The Advanced Therapies Apprenticeship Community (ATAC) has been established to develop talent to fuel the growth of the advanced therapies industry in the UK.Apprenticeships are already available in a range of areas – from laboratory science, to science manufacturing, process engineering, regulatory affairs, management and logistics – which have been designed in collaboration with accredited apprenticeship training providers and industryFor more information, visit advancedtherapiesapprenticeships.co.uk/.
Modern Apprenticeships in Life Sciences in Scotland explained Cell and Gene Therapy Catapult 2021-02-23 | The Modern Apprenticeship (MA) in Life Sciences is a 2-3 year programme that allows apprentices to develop the knowledge, skills and behaviour necessary to become occupationally competent in a laboratory environment and provide them with a pathway to complete further studies such as an HND or Degree.Visit advancedtherapiesapprenticeships.co.uk for more information.
How does ATAC support apprentices? Cell and Gene Therapy Catapult 2021-02-23 | The Advanced Therapies Apprenticeship Community (ATAC) has been established to train and upskill individuals in developing, manufacturing and delivering innovative therapies at scale.Our community of apprentices and employers is ever-growing. Not only will you receive ongoing support throughout your apprenticeship, but you will also play an important part in driving the advanced therapies industry forward.Become part of a growing network of expertise! Visit advancedtherapiesapprenticeships.co.uk for more information
How can apprenticeships benefit employers in the advanced therapies industry? Cell and Gene Therapy Catapult 2021-02-23 | Apprenticeships are an opportunity to upskill the existing workforce through quality training and assessment methods, as well as a route to recruit passionate talent into organisations.The Advanced Therapies Apprenticeship Community (ATAC) is the first apprenticeship programme to train and upskill individuals to work in the advanced therapies field. ATAC supports employers through recruiting and on-boarding apprentices, as well as with ongoing industry-led training, mentoring and assessment. Visit advancedtherapiesapprenticeships.co.uk to find out more information
Why pursue an advanced therapies apprenticeship? Cell and Gene Therapy Catapult 2020-03-19 | The Advanced Therapies Apprenticeship Community (ATAC) develops and facilitates apprenticeships for individuals looking to pursue a career in the advanced therapies industry.
Impact of the Advanced Therapies Apprenticeship Community Cell and Gene Therapy Catapult 2020-03-04 | For the second year running, the Advanced Therapies Apprenticeship Community (ATAC) hosted a roadshow of events during national apprenticeship week. The ATAC team met with current and future employers, training providers and apprentices in Manchester, Stevenage and Oxford, hosting workshops to convey the benefits of advanced therapies apprenticeship programmes. The ATAC programme has already had a tremendous impact, having grown significantly in the number of participating companies and apprentices enrolled in programmes in just over one year.
CGT Catapult event: Impact of the ATTC network after 18 months of operation Cell and Gene Therapy Catapult 2020-01-06 | Just 18 months ago, the Advanced Therapy Treatment Centre (ATTC) network was set up through funding from the UK Research and Innovation Industrial Strategy Challenge Fund. The network was set up in response to the challenge faced by the UK to bring cell and gene therapies into routine medical practice and anticipated dramatic increase in clinical trial activity across the country.Learn more: theattcnetwork.co.uk
CGT Catapult workshop: Addressing digital challenges for ATMP adoption by the NHS Cell and Gene Therapy Catapult 2019-12-11 | Highlights from the Cell and Gene Therapy Catapult's second annual Clinical Adoption Day workshop to address digital challenges in adoption of advanced therapy medicinal products (ATMPs) by the NHS. Learn more about our clinical adoption capabilities: ct.catapult.org.uk/capabilities
Advanced Therapies Apprenticeship Community explained Cell and Gene Therapy Catapult 2019-06-10 | Find out more about how and why our programmes have been created
Securing the advanced therapies talent pipeline through apprenticeships - Event highlights Cell and Gene Therapy Catapult 2019-06-10 | During National Apprenticeship Week apprentices and participating employers gathered at Oxford BioMedica to discuss how the first of its kind advanced therapies apprenticeship programme is key to meeting the industry demands for advanced therapies.
CGT Catapult event: Introducing the ATTC Network Cell and Gene Therapy Catapult 2018-11-01 | Highlights from our recent event launching the Advanced Therapy Treatment Centre (ATTC) Network. The ATTC Network is dedicated to establishing robust systems for the routine delivery of ATMPs throughout the NHS in the United Kingdom. Central to its mission is the acceleration of ATMP clinical trials, leveraging and building on existing expertise and resources.Learn more: theattcnetwork.co.uk
CGT Catapult Workshop: ATTCs, clinical infrastructure requirements and adoption of ATMPs Cell and Gene Therapy Catapult 2018-10-29 | The Cell and Gene Therapy Catapult hosted a workshop to tackle key challenges in advanced therapy adoption by the NHS. The workshop bought together expert stakeholders to explore how the Advanced Therapy Treatment Centre (ATTC) Network can drive adoption of cell and gene therapies.Learn more about the ATTC Network: theattcnetwork.co.uk
Building the CGT Catapult Stevenage Manufacturing Innovation Centre - Timelapse Cell and Gene Therapy Catapult 2018-05-01 | Construction was initiated on the Cell and Gene Therapy Catapult Stevenage Manufacturing Innovation Centre (MIC) in November 2015, and was completed in 2017.The Stevenage MIC is a 7,700m2 MHRA GMP-compliant facility licensed for clinical and commercial ATMP production. Operating through a unique collaboration model, we work with you to develop your manufacturing processes at scale, speed and according to GMP.Learn more: ct.catapult.org.uk/facilities/stevenage
Opening of the CGT Catapult Stevenage Manufacturing Innovation Centre Cell and Gene Therapy Catapult 2018-05-01 | On Monday 23rd April 2018, Business Secretary Greg Clark and Science Minister Sam Gyimah celebrated the opening of our large-scale GMP Manufacturing Innovation Centre (MIC) in Stevenage.Learn more: ct.catapult.org.uk/facilities/stevenage
Helping more patients access cell and gene therapies Cell and Gene Therapy Catapult 2018-01-02 | This programme, produced by ITN for the NHS Alliance, includes an interview with Keith Thompson outlines the issues in the industry, the role of the Cell and Gene Therapy Catapult and how we are helping more patients to access these therapies through the creation of a network of Advanced Therapy Treatment Centres.Cell and gene therapies are a revolution in healthcare, like nothing before seen by the healthcare system. The Advanced Therapy Treatment Centres will develop the processes to allow these therapies to be delivered on a routine basis in the NHS.
The Cell Therapy Catapult Official Opening Event Cell and Gene Therapy Catapult 2014-06-27 | The Cell Therapy Catapult official opening event was a great succes with many colleagues from industry, government and universities attending including RT Hon Dr. Vince Cable MP, Secretary of State for Business, Innovation and Skills.
